1) Ichizawa N et al:Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women:validation of the UICC T1 subgroup classification. Jpn J Clin Oncol 32(3):108-109, 2002
2) 国立研究開発法人国立がん研究センター がん情報サービスより. https://ganjoho.jp/reg_stat/statistics/stat/cancer/14_breast.html.
3) Gail MH:Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 100(14):1037-1041, 2008
4) The benefits and harms of breast cancer screening:an independent review. Lancet 380(9855):1778-1786, 2012
5) Suzuki A et al:Age-specific interval breast cancers in Japan:estimation of the proper sensitivity of screening using a populationbased cancer registry. Cancer Sci 99(11):2264-2267, 2008
6) Tice JA et al:Using clinical factors and mammographic breast density to estimate breast cancer risk:development and validation of a new predictive model. Ann Intern Med 148(5):337-347, 2008
7) Poplack SP et al:Digital breast tomosynthesis:initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenol 189(3):616-23, 2007
8) Cavagnetto F et al:'In vivo' average glandular dose evaluation:one-to-one comparison between digital breast tomosynthesis and full-field digital mammography. Radiat Prot Dosimetry 157(1):53-61, 2013
9) Phi XA et al:Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts-a systematic review and meta-analysis. BMC Cancer 18(1):380, 2018
10) Berg WA et al:Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. Jama 307(13):1394-1404, 2012
12) Riedl CC et al:Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33(10):1128-1135, 2015
13) Kuhl CK et al:Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23(33):8469-8476, 2005
14) Arai M et al:Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer:first report after establishment of HBOC registration system in Japan. J Hum Genet 63(4):447-457, 2018
15) Ha SM et al:Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations. AJR Am J Roentgenol 209(4):920-928, 2017
16) Ide Y et al:Frequency of high-risk hormone receptor-positive breast cancer patients was much higher in Japanese breast cancer patients with germline BRCA1/2 mutations than in sporadic breast cancer patients. Breast J 27(2):188-190, 2021
17) Warner E et al:Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Jama 292(11):1317-1325, 2004
18) Kemp Jacobsen K et al:Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer 137(9):2198-2207, 2015
19) Tozaki M et al:Current status of breast cancer screening in high-risk women in Japan. Breast Cancer 28(6):1181-1187, 2021
20) Daly MB et al:Genetic/Familial High-Risk Assessment:Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(1):77-102, 2021
21) 日本乳癌学会:疫学・診断編. 日本乳癌学会:乳癌診療ガイドライン 2, 金原出版, 304, 2018
22) Familial breast cancer:collaborative reanalysis of individual data from 52 epidemiological studies including 58, 209 women with breast cancer and 101,986 women without the disease. Lancet. 358(9291):1389-1399, 2001
23) Yala A et al:Optimizing risk-based breast cancer screening policies with reinforcement learning. Nat Med 28(1):136-143, 2022
24) 桑山 隆:画像診断技術の動向と臨床応用 BRCA 遺伝子変異陽性患者における乳がんの画像診断, Women's Imaging 2019 Breast Imaging (Vol.14) Precision Medicine時代におけるライフステージと乳がん画像診断. 34(8):62-64, INNERVISION, 2019